Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Cardiovascular Risk Reduction in Postpartum Hypertensive Pregnancies
NCT06785116Phase 4Recruiting
- Sponsor
- University of Michigan
- Start
- Mar 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin, sponsored by University of Michigan. Started Mar 2025; status: recruiting.
02
Drugs
dapagliflozin
Beyond the preview
Go deeper on NCT06785116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06785116.